Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 434-442

  Kraeft, Stine Kathrein ^a   Sutherland, Rebecca ^a   Gravelin, Laura ^a   Hu, Guan Hong ^a   Ferland, Louis H ^a   Richardson, Paul ^a   Elias, Anthony ^a   Chen, Lan Bo ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOFLUORESCENCE; BLOOD ANALYSIS; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CELL COUNT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LABORATORY AUTOMATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

AUTOMATION; BONE MARROW; BONE MARROW CELLS; BREAST NEOPLASMS; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MICROCOMPUTERS; MICROSCOPY, FLUORESCENCE; NEOPLASM STAGING; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0033970143     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Mitelman, F. Catalogue of chromosome aberrations in cancer, 2nd ed. New York: Alan R. Liss, 1985.
2. Pantel, K., Izbicki, J. R., Angstwurm, M., Braun, S., Passlick, B., Karg, O., Thetter, O., and Riethmuller, G. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res., 53: 1027-1031, 1993.
3. Cote, R. J., Rosen, P. P., Lesser, M. L., Old, L. J., and Osborne, M. P. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol., 9: 1749-1756, 1991.
4. Mansi, J. L., Easton, D., Berger, U., Gazet, J. C., Ford, H. T., Dearnaley, D., and Coombes, R. C. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur. J. Cancer, 27: 1552-1555, 1991.
5. Diel, I. J., Kaufmann, M., Goerner, R., Costa, S. D., Kaul, S., and Bastert, G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J. Clin. Oncol., 10: 1534-1539, 1992.
6. Harbeck, N., Untch, M., Pache, L., and Eiermann, W. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br. J. Cancer, 69: 566-571, 1994.
7. Jauch, K. W., Heiss, M. M., Gruetzner, U., Funke, I., Pantel, K., Babic, R., Eissner, H. J., Riethmueller, G., and Schildberg, F. W. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J. Clin. Oncol., 14: 1810-1817, 1996.
8. Thorban, S., Roder, J. D., Pantel, K., and Siewert, J. R. Immunocytochemical detection of isolated epithelial tumor cells in bone marrow of patients with pancreatic carcinoma. Am. J. Surg., 172: 297-298, 1996.
9. Pantel, K., Izbicki, J., Passlick, B., Angstwurm, M., Haussinger, K., Thetter, O., and Riethmuller, G. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet, 347: 649-653, 1996.
10. Cote, R. J., Beattie, E. J., Chaiwun, B., Shi, S. R., Harvey, J., Chen, S. C., Sherrod, A. E., Groshen, S., and Taylor, C. R. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann. Surg., 222: 415-423, 1995.
11. Gribben, J. G., Neuberg, D., Barber, M., Moore, J., Pesek, K. W., Freedman, A. S., and Nadler, L. M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood, 83: 3800-3807, 1994.
12. Ross, A. A., Cooper, B. W., Lazarus, H. M., Mackay, W., Moss, T. J., Ciobanu, N., Tallman, M. S., Kennedy, M. J., Davidson, N. E., Sweet, D., Winter, C., Akard, L., Jansen, J., Copelan, E., Meagher, R. C., Herzig, R. H., Klumpp, T. R., Kahn, D. G., and Warner, N. E. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques (see comments). Blood, 82: 2605-2610, 1993.
13. Braun, S., Muller, M., Hepp, F., Schlimok, G., Riethmuller, G., and Pantel, K. Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status (comment). J. Natl. Cancer Inst., 90: 1099-1101, 1998.
14. Pantel, K. Detection of minimal disease in patients with solid tumors. J. Hematother., 5: 359-367, 1996.
15. Ross, A. A. Minimal residual disease in solid tumor malignancies: a review. J. Hematother., 7: 9-18, 1998.
16. Pantel, K., and Riethmuller, G. Methods for detection of micrometastatic carcinoma cells in bone marrow, blood, and lymph nodes. Onkologie, 18: 394-401, 1995.
17. Radbruch, A., and Recktenwald, D. Detection and isolation of rare cells. Curr. Opin. Immunol., 7: 270-273, 1995.
18. Sharp, J. G., Bishop, M., Chan, W. C., Greiner, T., Joshi, S. S., Kessinger, A., Reed, E., Sanger, W., Tarantolo, S., Traystman, M., and Vose, J. Detection of minimal residual disease in hematopoietic tissues. Ann. NY Acad. Sci., 770: 242-261, 1995.
19. Datta, Y. H., Adams, P. T., Drobyski, W. R., Ethier, S. P., Terry, V. H., and Roth, M. S. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol., 12: 475-482, 1994.
20. Krismann, M., Todt, B., Schroder, J., Gareis, D., Muller, K. M., Seeber, S., and Schutte, J. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol., 13: 2769-2775, 1995.
21. Gerhard, M., Juhl, H., Kalthoff, H., Schreiber, H. W., Wagener, C., and Neumaier, M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. Clin. Oncol., 12: 725-729, 1994.
22. Noguchi, S., Aihara, T., Nakamori, S., Motomura, K., Inaji, H., Imaoka, S., and Koyama, H. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer (Phila.), 74: 1595-1600, 1994.
23. Racila, E., Euhus, D., Weiss, A. J., Rao, C., McConnell, J., Terstappen, L. W., and Uhr, J. W. Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. USA, 95: 4589-4594, 1998.
24. Gross, H. J., Verwer, B., Houck, D., Hoffman, R. A., and Recktenwald, D. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7). Proc. Natl. Acad. Sci. USA, 92: 537-541, 1995.
25. Mansi, J. L., Mesker, W. E., McDonnell, T., Van Driel-Kulker, A. M., Ploem, J. S., and Coombes, R. C. Automated screening for micrometastases in bone marrow smears. J. Immunol. Methods, 112: 105-111, 1988.
26. Mesker, W. E., v. d. Burg, J. M., Oud, P. S., Knepfle, C. F., Ouwerkerk-v Velzen, M. C., Schipper, N. W., and Tanke, H. J. Detection of immunocytochemically stained rare events using image analysis. Cytometry, 17: 209-215, 1994.
27. Lee, B. R., Haseman, D. B., and Reynolds, C. P. A digital image microscopy system for rare-event detection using fluorescent probes. Cytometry, 10: 256-262, 1989.
28. Clatch, R. J., Walloch, J. L., Foreman, J. R., and Kamentsky, L. A. Multiparameter analysis of DNA content and cytokeratin expression in breast carcinoma by laser scanning cytometry. Arch. Pathol. Lab. Med., 121: 585-592, 1997.
29. Kamentsky, L. A., Burger, D. E., Gershman, R. J., Kamentsky, L. D., and Luther, E. Slide-based laser scanning cytometry. Acta Cytol., 41: 123-143, 1997.
30. Pantel, K., Schlimok, G., Angstwurm, M., Weckermann, D., Schmaus, W., Gath, H., Passlick, B., Izbicki, J. R., and Riethmuller, G. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother., 3: 165-173, 1994.
31. Pantel, K., Felber, E., and Schlimok, G. Detection and characterization of residual disease in breast cancer. J. Hematother., 3: 315-322, 1994.
32. Schulze, R., Schulze, M., Wischnik, A., Ehnle, S., Doukas, K., Behr, W., Ehret, W., and Schlimok, G. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant., 19: 1223-1228, 1997.
33. Thorban, S., Roder, J. D., Nekarda, H., Funk, A., Pantel, K., and Siewert, J. R. Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: detection and prognostic significance. World J. Surg., 20: 567-572, 1996.
34. Bumol, T. F., Marder, P., DeHerdt, S. V., Borowitz, M. J., and Apelgren, L. D. Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibody. Hybridoma, 7: 407-415, 1988.
35. Varki, N. M., Reisfeld, R. A., and Walker, L. E. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res., 44: 681-687, 1984.
36. Schulz, G., Cheresh, D. A., Varki, N. M., Yu, A., Staffileno, L. K., and Reisfeld, R. A. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res., 44: 5914-5920, 1984.
37. Cheresh, D. A., Rosenberg, J., Mujoo, K., Hirschowitz, L., and Reisfeld, R. A. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis. Cancer Res., 46: 5112-5118, 1986.
38. Ritter, G., and Livingston, P. O. Ganglioside antigens expressed by human cancer cells. Semin. Cancer Biol., 2: 401-409, 1991.
39. Franklin, W. A., Shpall, E. J., Archer, P., Johnston, C. S., Garza-Williams, S., Hami, L., Bitter, M. A., Bast, R. C., and Jones, R. B. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res. Treat., 41: 1-13, 1996.
40. Allgayer, H., Heiss, M. M., Riesenberg, R., Babic, R., Jauch, K. W., and Schildberg, F. W. Immunocytochemical phenotyping of disseminated tumor cells in bone marrow by uPA receptor and CK18: investigation of sensitivity and specificity of an immunogold/alkaline phosphatase double staining protocol. J. Histochem. Cytochem., 45: 203-212, 1997.
41. Christofori, G., and Semb, H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci., 24: 73-76, 1999.
42. Paul, R., Ewing, C. M., Jarrard, D. F., and Isaacs, W. B. The cadherin cell-cell adhesion pathway in prostate cancer progression. Br. J. Urol., 1: 37-43, 1997.
43. Holzmann, B., Gosslar, U., and Bittner, M. α 4 integrins and tumor metastasis. Curr. Top. Microbiol. Immunol., 231: 125-141, 1998.
44. Sass, P. M. The involvement of selectins in cell adhesion, tumor progression, and metastasis. Cancer Invest., 16: 322-328, 1998.
45. Ziober, B. L., Lin, C. S., and Kramer, R. H. Laminin-binding integrins in tumor progression and metastasis. Semin. Cancer Biol., 7: 119-128, 1996.
46. Syrigos, K. N., Harrington, K. J., and Pignatelli, M. Role of adhesion molecules in bladder cancer: an important part of the jigsaw. Urology, 53; 428-434, 1999.
47. Sneath, R. J., and Mangham, D. C. The normal structure and function of CD44 and its role in neoplasia. Mol. Pathol., 51: 191-200, 1998.
48. Friedl, P., Brocker, E. B., and Zanker, K. S. Integrins, cell matrix interactions, and cell migration strategies: fundamental differences in leukocytes and tumor cells. Cell Adhes. Commun., 6: 225-236, 1998.
49. Oosterwijk, J. C., Knepfle, C. F., Mesker, W. E., Vrolijk, H., Sloos, W. C., Pattenier, H., Ravkin, I., van Ommen, G. J., Kanhai, H. H., and Tanke, H. J. Strategies for rare-event detection: an approach for automated fetal cell detection in maternal blood. Am. J. Hum. Genet., 63: 1783-1792, 1998.
50. Osborne, M. P., Wong, G. Y., Asina, S., Old, L. J., Cote, R. J., and Rosen, P. P. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res., 51: 2706-2709, 1991.
51. Allgayer, H., Heiss, M. M., Riesenberg, R., Grutzner, K. U., Tarabichi, A., Babic, R., and Schildberg, F. W. Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res., 57: 1394-1399, 1997.
52. Pantel, K., Schlimok, G., Braun, S., Kutter, D., Lindemann, F., Schaller, G., Funke, I., Izbicki, J. R., and Riethmuller, G. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. Natl. Cancer Inst., 85: 1419-1424, 1993.
53. Riesenberg, R., Oberneder, R., Kriegmair, M., Epp, M., Bitzer, U., Hofstetter, A., Braun, S., Riethmuller, G., and Pantel, K. Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells. Histochemistry, 99: 61-66, 1993.
54. Moss, T. J., Reynolds, C. P., Sather, H. N., Romansky, S. G., Hammond, G. D., and Seeger, R. C. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N. Engl. J. Med., 324: 219-226, 1991.
55. Ross, A. A., Loudovaris, M., Hazelton, B., Weaver, C. H., Schwartzberg, L., and Bender, J. G. Immunocytochemical analysis of tumor cells in pre-and post-culture peripheral blood progenitor cell collections from breast cancer patients. Exp. Hematol., 23: 1478-1483, 1995.
56. Ross, A. A., Miller, G. W., Moss, T. J., Kahn, D. G., Warner, N. E., Sweet, D. L., Louie, K. G., Schneidermann, E., Pecora, A. L., Meagher, R. C., Herzig, R. H., Collins, R. H., and Fay, J. W. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer. Bone Marrow Transplant, 15: 929-933, 1995.
57. Vredenburgh, J. J., Silva, O., Tyer, C., DeSombre, K., Abou-Ghalia, A., Cook, M., Layfield, L., Peters, W. P., and Bast, R. C., Jr. A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrow. J. Hematother., 5: 57-62, 1996.
58. Ross, A. A., Layton, T. J., Ostrander, A. B., Passos-Coelho, J. L., Davis, J. M., Huelskamp, A. M., Noga, S. J., Davidson, N. E., Kennedy, M. J., Cooper, B. W., Gerson, S. L., Lazarus, H. M., Holland, K., Gluck, S., Moss, T. J., Kaubish, A., Vahdat, L., and Antman, K. Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts. J. Hematother., 5: 549-552, 1996.
59. Vredenburgh, J. J., Silva, O., Broadwater, G., Berry, D., DeSombre, K., Tyer, C., Petros, W. P., Peters, W. P., and Bast, R. C., Jr. The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support. Biol. Blood Marrow Transplant., 3: 91-97, 1997.